- Our Story
- Our Products
- Our Science
- Our People & Citizenship
-
Investors
- Reports and Filings
- Presentations & Earnings Calls
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Details of Shares for transfer to IEPF May 2021
- Notice pursuant to IEPF Rules, May 2021
- Governance
- Investor Services
-
ESG profile
- Media
- Partners
- Contact Us
Dr. Reddy's in the news
-
From Babu to Corporate Honcho
Career as Asset - Case Studies of successful career switches Prabir Jha's career focus did not waver nor did his professional plans go awry after quitting his cushy government job
Click Here for the Complete Story [PDF Format] -
Betting on biotech
Dr. Reddy's is concentrating now on biotechnology-based products and going for acquisitions to provide a base for launching them
Click Here for the Complete Story [PDF Format] -
The Best Companies to work for in India
A BT-Mercer-TNS survey of India's best employers
Click Here for the Complete Story [PDF Format] -
Targeting the poor sweetens the profits pill
Indian pharma multinational Dr Reddy’s chief executive G V Prasad says that patient needs and shareholder value go hand-in-hand.
Click Here for the Complete Story [PDF Format] -
Meet Anji Reddy, The Philanthropist
Ask for directions to Dr. Reddy's Laboratories Ltd. in this industrial city in central Mexico and locals will give you a curious look.Many are unfamiliar with the drug maker, one of India's largest pharmaceutical companies, which purchased a production fa
